In the present study, we aimed to assess if anti-alpha-synuclein shRNA-MC RVG-EV could downregulate alpha-synuclein expression in organs affected in pre-clinical stages of Parkinson’s disease, as intestine and spinal cord. This evidence concerns the gene SNCA and Parkinson disease.